Verma, Parul
Ranasinghe, Kamalini
Prasad, Janani
Cai, Chang
Xie, Xihe
Lerner, Hannah
Mizuiri, Danielle
Miller, Bruce
Rankin, Katherine
Vossel, Keith
Cheung, Steven W.
Nagarajan, Srikantan S.
Raj, Ashish
Funding for this research was provided by:
Alzheimer's Association (AARFD-22-923931)
National Institutes of Health (R01EB022717, R01NS092802)
Ricoh MEG Inc
Article History
Received: 7 December 2023
Accepted: 4 March 2024
First Online: 19 March 2024
Declarations
:
: Informed consent was obtained from all participants and the study was approved by the Institutional Review Board (IRB) at UCSF (UCSF-IRB 10-02245).
: All authors consent publication of this article.
: Bruce Miller serves as Medical Director for the John Douglas French Foundation; Scientific Director for the Tau Consortium; Director/Medical Advisory Board of the Larry L. Hillblom Foundation; and Scientific Advisory Board Member for the National Institute for Health Research Cambridge Biomedical Research Centre and its subunit, the Biomedical Research Unit in Dementia, UK. Srikantan Nagarajan is a scientific consultant to MEGIN Inc. and a Medical Strategy Adviser to Hippoclinic Inc. He served on the scientific advisory board for Rune Labs Inc. from 2019-2022 and was the recipient of an industry contract from Ricoh MEG Inc.